Simian virus 40 large T antigen is a multifunctional protein that is encoded by the early region of the viral genome. We constructed fusion proteins between simian virus 40 large T antigen and P-galactosidase by cloning Hindlll fragments A and D of the virus into the HindlIl sites of expression vectors pUR290, pUR291, and pUR292. Large amounts of the fusion protein were synthesized when the DNA fragment encoding part of simian virus 40 large T antigen was in frame with the lacZ gene of the expression vector. Using Western blotting and a competition radioimmunoassay, we assessed the binding of existing anti-T monoclonal and polyclonal antibodies to the two fusion proteins. Several monoclonal antibodies reacted with the protein encoded by the fragment A construction, but none reacted with the protein encoded by the fragment D construction. However, mice immunized with pure 0-galactosidase-HindIII fragment D fusion protein produced good levels of anti-T antibodies, which immunoprecipitated simian virus 40 large T antigen from lytically infected cells, enabling derivation of monoclonal antibodies to this region of large T antigen. Therefore, the fusion proteins allowed novel epitopes to be discovered on large T antigen and permitted the precise localization of epitopes recognized by existing antibodies. The same approach can also be used to produce antibodies against defined regions of any gene.
Simian virus 40 (SV40) large T antigen is a complex protein (Mr, 81,632; 708 amino acids) (25) that is normally expressed at low levels in virus-infected cells, where it is responsible for the initiation of viral DNA synthesis. In nonpermissive systems SV40 induces cell transformation. Large T antigen is required both to initiate and to maintain the transformed state.
Insight into the structure and function of large T antigen has been obtained through immunochemical studies by using, initially, polyclonal antibodies and, more recently, monoclonal reagents. Large libraries of monoclonal antibodies to large T antigen have been produced (1, 12, 14, 17 ; J. Yewdell and D. P. Lane, unpublished data). Some of these antibodies are able to block functional activities of large T antigen (3), whereas others appear to distinguish a discrete subset within the infected or transformed cells (12, 14) . To exploit fully the potential of these reagents, it is important to localize precisely their binding sites. Of course, this is a general problem in the use of monoclonal antibodies in investigations of protein antigens.
In this paper we describe the subcloning of fragments of the gene encoding large T antigen to produce 3-galactosidase-large T antigen fusion proteins. These proteins were used to map antibody binding sites, to demonstrate the presence of putative immunologically silent regions, and to raise both monoclonal and polyclonal antibodies to these epitopes. Our results suggest that an approach involving the production of fusion proteins is an excellent general method for mapping monoclonal antibody binding sites and for generating antibodies against uncharacterized open reading frames. supE F'lacfQZ-l&M15pro'] (19) and F'llrecA [(lac pro)Athi rifA strA recA F'laclfl Z-pro+] (22) .
MATERIALS AND METHODS
Plasmid vectors pUR290, pUR291, and pUR292 have been described previously (23) .
The basic growth media used were L-broth (1% tryptone [Difco Laboratories], 0.5% yeast extract, 1% NaCl, pH 7.5) and L-agar (1.5% agar in L-broth). Ampicillin was used at a concentration of 100 jig/ml in liquid cultures and at a concentration of 50 jig/ml on L-agar plates.
Isopropyl thiogalactosidase (IPTG; Sigma Chemical Co.) was used at a concentration of 500 p.M in the growth media to induce expression of P-galactosidase and the fusion proteins.
Cells and antibodies. CV1 monkey cells were cultured in Dulbecco modified Eagle medium supplemented with 10% fetal calf serum, 615 U of penicillin per ml, and 123 U of streptomycin per ml. Cells were infected with SV40 (multiplicity of infection, 5 PFU/cell) at confluency.
Anti-SV40 large T antigen monoclonal antibodies PAb419, PAb423, PAb404, PAb409, PAb416, PAb430, PAb431, PAb435, PAb439, PAb441 (14) , PAb204 (17) , and PAb6O6 (kind gift of L. Gooding; L. Gooding, manuscript in preparation) and anti-,B-galactosidase monoclonal antibody BG-2 (from C. Kintner, Medical Research Council Biophysics Unit; C. Kintner, unpublished data) were used as crude cell supernatants.
SDS-PAGE. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was carried out as described by Laemmli (16) . Gels were stained in a solution containing 0.1% Coomassie blue, 10% acetic acid, and 25% propanol and destained in a solution containing 7.5% acetic acid and 25% methanol.
Construction and identification of fusion proteins. A vector linearized with Hindlll was ligated with an excess of a gel-purified SV40 HindIll fragment (18) . This ligation mixture was used to transform competent E. coli cells having the lacZ phenotype (13) .
The colonies obtained were gridded out on nitrocellulose filters and probed with the nick-translated SV40 HindIlI fragment (21) .
After autoradiography, 1.5-ml IPTG-induced overnight cultures of colonies that hybridized to the probe were prepared, and the cell pellets were washed in modified phosphate-buffered saline (PBS; 150 mM NaCl, 3 mM KCI, 8 mM NaH2PO4, 1.5 mM KH2PO4, pH 7.2), suspended in 300 ,u of SDS-PAGE sample buffer, and sonicated.
Protein expression was analyzed on 8.5% SDS-polyacrylamide gels.
Western blotting and immunological analysis. Electroelution of proteins from an SDS-polyacrylamide gel onto nitrocellulose was performed as described by Burnette (2) . The following sequence of rinses and incubations was carried out (J. Yewdell and D. Lane, manuscript in preparation): incubated overnight at 4°C in bloc-king buffer (3% bovine serum albumin [BSA] in PBS); rinsed in PBS; incubated overnight at 4°C in crude monoclonal antibody supernatant; rinsed in PBS; rinsed twice for 20 min in PBS containing 1% Nonidet P-40 (NP-40); rinsed twice for 20 min in PBS; incubated overnight at 4°C in preadsorbed rabbit anti-mouse immunoglobulins coupled to horseradish peroxidase; rinsed in PBS; rinsed twice for 20 min in PBS containing 1% NP-40; rinsed twice for 20 min in 0.1 x SSC (1 x SSC is 150 mM NaCl plus 15 mM trisodium citrate, pH 7.0); rinsed in PBS containing 0.1% NP-40; rinsed three times for 20 min in PBS.
The substrate used was 50 mg of 4-chloro-1-naphthal in 1 ml of ethanol; this preparation was freshly diluted 1:100 in PBS and filtered, and hydrogen peroxide (30%) added at a dilution of 1:5,000.
Preparation of E7 cell extract for use in Western blotting. Extracts of E7 cells (an SV40-transformed mouse fibroblast cell line) were prepared by lysing 5 x 106 cells in 1 ml of boiling SDS-PAGE sample buffer (2x concentrated). The extract was sonicated and stored at -20°C.
Preadsorption Preclearance of non-specifically reacting material from the cell extract was carried out by incubating the preparation with normal rabbit serum and then with Staphylococcus aureus Cowan 1.
(ii) Immunoprecipitation. Each immunoprecipitation reaction was carried out by using a volume of cell supernatant equivalent to approximately 3 x 106 cells.
Each cell extract was incubated with 100 ,l of monoclonal antibody supernatant or 10 ,u of mouse serum overnight at 4°C. Cell extracts incubated with monoclonal antibody were also incubated with 5 ,ug of rabbit anti-mouse immunoglobulins and S RI of normal rabbit serum. The cell extracts were then incubated with 50 RI of S. aureus Cowan 1 for 15 min at 4°C, and the cell pellets were washed sequentially in the following buffers: NET containing 1% NP-40; 1% NP-40-0.1% SDS-500 mM LiCI-50 mM Tris (pH 8.0); 1% NP-40-600 mM NaCl-50 mM Tris (pH 8.0); 1% NP-40-0.1% SDS-100 mM NaCl-50 mM Tris (pH 8.0); 0.05% NP-40-1% BSA-150 mM NaCI-5 mM EDTA-50 mM Tris (pH 8.0); and NET. Then each cell pellet was suspended in NET, transferred to a fresh tube, and centrifuged. The resulting pellet was suspended in 50 ,ul of SDS-PAGE sample buffer, boiled for 2 min, and centrifuged; the supernatant was transferred to a fresh tube, boiled for 5 min, and run on an 8.5% SDS-polyacrylamide gel.
The gel was stained, destained, incubated for 1 h in EN3HANCE (New England Nuclear Corp.), washed in water for 1 h, dried, and autoradiographed by using Fuji RX X-ray film.
Staining of CV1 cells. At 24 h after infection or mock-infection with SV40, CV1 cells were fixed in 50% methanol-50% acetone for 2 min and dried thoroughly, and 2 [lI of monoclonal antibody supernatant or mouse serum was spotted onto the cells. After 2 to 4 h in a humid environment, the plates were washed five times with PBS.
Then 1 ml of a 1:100 dilution of rabbit anti-mouse immunoglobulins coupled to horseradish peroxidase in PBS containing 1% BSA and 5% fetal calf serum was added to each 90-mm dish, and the preparation was incubated overnight at 40C. After five washes with PBS, the substrate was added. The substrate was a saturated solution of o-dianisidine in ethanol that was freshly diluted 1:100 in PBS and filtered; H202 (30%) was added at a dilution of 1:5,000.
IRIA. The presence of epitopes on the fusion proteins recognized by anti-T monoclonal antibodies was assayed by an inhibition radioimmunoassay (IRIA). SV40 large T antigen was purified from AD5-SVR111-infected 293 cells by immunoaffinity chromatography on a PAb419 column and iodinated by using the iodogen method to a specific activity of 6 ,uCi/,ug (V. Simanis and D. P. Lane, manuscript in preparation).
Plastic microtiter trays (96 wells; type 3911; BD Labware) were coated overnight with 100 ,u1 of rabbit anti-mouse immunoglobulins (30 ,ug/ml in 50 mM sodium phosphate buffer, pH 7.5) per well and then blocked overnight by using 5% BSA in 50 mM sodium' phosphate buffer (pH 7.5). To each well, 50 pI of a 1:10 or 1:2.5 dilution of anti-large T antigen monoclonal antibody supernatant in PBS containing 1% BSA and 10% fetal calf serum was added; the preparations were incubated overnight and then washed with PBS containing 0.05% NP-40, followed by washing with PBS. A 100-pI portion of a 1:10 dilution of E. coli extract was added to each well, followed by 50 pA of 1251-labeled large T antigen (approximately 4 ng; 10,000 cpm). The plate was incubated overnight and washed with PBS containing 0.05% NP-40, followed by washing with PBS, and each well was counted for 10 s.
Preparation of the E. coli extract used for the IRIA. A 100-ml IPTG-induced, overnight culture was processed as described above in the section on purification of the fusion proteins. The cell debris fraction was suspended in 10 ml of PBS and sonicated on ice for multiple 20-s bursts. The cell extract was stored at -20°C.
RESULTS
Construction and identification of fusion proteins. We constructed fusion proteins between fragments of SV40 large T antigen and P-galactosidase by using expression vectors pUR290, pUR291, and pUR292 (23) , which allow cloning of DNA fragments into unique restriction enzyme sites at the 3' end of the lacZ gene in each of the three reading frames. Therefore, the fusion proteins consisted of all of 1-galactosidase at the N terminus and a fragment of SV40 large T antigen at the C terminus.
Two HindlIl fragments of SV40 DNA were cloned into the expression vectors, Hindlll fragment D (nucleotides 4,002 to 3,476), which encodes the middle portion of large T antigen (amino acids 271 to 446), and HindIII fragment A (nucleotides 3,476 to 1,708), which encodes the C-terminal portion of large T antigen (amino acids 446 to 708) in one orientation and a large portion of VP1 protein (amino acids 69 to 362) in the other. Clones carrying insertions were identified by using a nick-translated SV40 DNA probe, and fusion protein expression was investigated by using SDS-PAGE (Fig. 1) .
IPTFG was used to induce expression of the lacZ gene. The high copy number of the expression vectors resulted in production of ,B-galactosidase or the fusion protein in abundant quantities (a 1-ml IPTG-induced overnight culture contained approximately 40 pug of fusion protein). The clones containing an insertion in the correct orientation and framing with respect to the lacZ gene produced a fusion protein band having a higher molecular weight than ,B-galactosidase, which was easily identifiable due to its abundant production (Fig.  1) . The observed molecular weights of the fusion proteins showed a close correlation with the calculated molecular weights (Table 1) .
In these experiments, the early region fragments were inserted into all three vectors (that is, in all three reading frames with respect to lacZ) ( Table 1) . This was to check that the vector which produced a fusion protein was the vector which was predicted to contain the insertion in the correct orientation and reading frame with lacZ. The orientation of the insertion was also checked by restriction enzyme mapping.
The stability of the fusion proteins varied; thegal'actosidase-HindIII fragment D fusion protein showed no obvious degradation, whereas the ,B-galactosidase-Hindlll fragment A fusion proteins of both orientations (T antigen and VP1) were unstable and produced a pattern of lowermolecular-weight bands in addition to the full fusion protein band (Fig. 1) (Fig. 2) . The control antibodies used included PAb419, which recognizes the N-terminal segment of large T antigen (nucleotides 5,163 to 4,918; amino acids 1 to 82) (14) and reacted with the large T antigen from E7 cells (an SV40-transformed mouse fibroblast line), and BG-2, which reacted with ,B-galactosidase and the fusion proteins (data not shown).
PAb423 reacted with large T antigen from E7 cells and only the lowest-mobility band of the ,B-galactosidase-HindIII fragment A fusion protein. There was also some cross-reactivity with a protein of the E7 cell extract (p50), which has been previously observed (7) . PAb2O4 reacted with large T antigen from E7 cells and the ,B-galactosidase-HindIll fragment A fusion protein, including the putative degradation bands. Recognition by PAb2O4 was very sensitive compared with the amount of protein easily visible on SDS-PAGE gels (Fig. 1) .
Since PAb423 binds to the C terminus of large T antigen and PAb2O4 binds to an internal site, the pattern of blotting shown in Fig. 2 can be explained if the 3-galactosidase-HindlIl fragment A fusion protein is preferentially degraded from its C terminus. Thus, the binding site of PAb423 would be lost very quickly, resulting in staining of only the highest-molecular-weight band (presumably the nondegraded fusion protein), whereas the binding site of PAb2O4 would be retained in more of the lower-molecular- weight bands, as observed. Degradation must also occur internally, as bands at lower molecular weights than 1-galactosidase were observed.
(ii) IRIA. An IRIA, in which we used anti-large T antigen (17) . This was confirmed by using deletion mutants (4) in which the PAb2O4 site was mapped between nucleotides 3,571 and 3,289 (amino acids 417 and 509). However, these studies showed that PAb2O4 binds specifically to a P-galactosidase-large T antigen fusion protein corresponding to SV40 nucleotides 3,476 to 2,694 (amino acids 448 to 708). By combining the above data, the PAb2O4 binding site can be mapped to a region of 64 amino acids (amino acids 448 to 509) (Fig. 3) . bNucleotide residues of the SV40 genome.
' Amino acid residues of large T antigen. Immune response to the fusion proteins. A polyclonal antibody (RbaD2) raised against SV40 large T antigen-related peptide Ad2+ D2, which binds to native large T antigen, reacted with the 3-galactosidase-HindIII fragment D fusion protein in Western blotting experiments. However, the ,B-galactosidase-HindIII fragment D fusion protein showed no binding to any of the monoclonal antibodies tested which were thought to be directed against this region of large T antigen. It should be noted that most of the antibodies which immunoprecipitated the Ad2+ ND2 56,000-and 42,000-dalton proteins but not the Ad2+ ND1 28,000-dalton protein recognized denaturation-sensitive epitopes.
Pure 3-galatosidase-HindIII fragment D fusion protein was used to immunize mice, and the sera obtained were tested for anti-large T antigen activity. In radioimmunoassay studies, Western blotting experiments (data not shown), and immunoprecipitation experiments in which SV40-infected CV1 cells were used (Fig. 4) , the sera were shown to contain specific anti-large T antigen activity. SV40-infected CV1 cells also showed clear nuclear staining when the anti-,Bgalactosidase-HindIll fragment D fusion protein sera were used. Spleen cells from an immunized mouse were fused with SP20/AG14 cells, and the fusions were plated out over 800 wells. Of 100 hybridomas screened, 2 gave positive results in the IRIA and cell staining and enzyme-linked substrate adsorption assays, and have been shown to react specifically with the region of large T antigen corresponding to HindIll fragment D. Thus, fusion proteins may prove to be invaluable in the production of monoclonal antibodies which can then be used in further detailed analysis of the antigen.
DISCUSSION
The expression vectors which we used facilitated the construction of fusion proteins by the presence of a number of different restriction enzyme sites at the 3' end of the lacZ gene. Identification and isolation of the fusion protein were aided by the abundant production, after induction with IPTG, of lacZ gene expression. The Previous examples of P-galactosidase fusion proteins have not had the advantage of the abundant production of the fusion proteins (11, 20, 24) . Stanley (24) showed that insertion at the 5' end of the lacZ gene gave rise to fusion proteins which were rapidly degraded, whereas insertion at the 3' end gave rise to stable, insoluble fusion proteins. The stability of 3' end insertion fusion proteins probably explains the success of the Xgtll expression library system (26); 5' end insertions are not always unstable (11) . This effect may be intrinsic to the particular insertion sequence and possibly to the bacterial strain used as host.
The pUR290, pUR291, and pUR292 vectors were originally designed for the cloning of cDNA. The absoluteness of the reading frame allows cloning into the correct vector, amplification of the DNA, and production of the fusion protein. The defined insertion point also allows the establishment of an open reading frame. This is in contrast to expression vectors in which insertion of DNA is by homopolymer tailing, as there is no defined reading frame between lacZ and the insertion (11, 24) .
The Western blotting and IRIA data showed that PAb2O4 binds to the P-galactosidase-HindIII fragment A fusion protein. PAb2O4 is exceptional in that, of the monoclonal antibodies recognizing denaturation-resistant sites, it is the only one that shows binding to the Ad2+ ND2 42,000-dalton protein and not to the Ad2+ ND2 28,000-dalton protein (14, 17) . It is also interesting since it cross-reacts with a growthregulated cellular protein, p68 (17) , and inhibits the ATPase activity of large T antigen (3 O'Connell and L. R. Gooding manuscript in preparation). A possible explanation is that the degradation is due to partitioning of the fusion protein into the bacterial membrane. The Ad2+ ND1 28,000-dalton protein, which contains this hydrophobic stretch, has been clearly shown to localize to the plasma membrane of Ad2+ ND1-infected cells, where it can act as an antibody binding site and as a target for cytotoxic T cells (8; O'Connell et al., manuscript in preparation). The N terminus of large T antigen is also thought to be exposed on the outside surface of the cell (9), whereas the central region of the molecule (corresponding to the region present in the P-galactosidase-HindIII fragment D fusion protein) is thought to be exposed to the cytoplasm (10). The P-galactosidase-HindIII fragment D fusion protein does not contain a hydrophobic region and is also not degraded.
The IRIA can be used to provide information on the binding of monoclonal antibodies with denaturation-resistant or -sensitive sites, since antibodies of both types are able to bind iodinated large T antigen efficiently. The data from the IRIA correlate with the information previously available on the positions of the binding sites of the monoclonal antibodies used. Those antibodies recognizing a site at the C terminus (PAb423, PAb4O9, PAb4O6, and PAb6O6) also bind to the P-galactosidase-HindIII fragment A fusion protein.
Those antibodies recognizing N-terminal sites (PAb416, PAb431, PAb430, PAb435, PAb439, and PAb441) do not bind to the ,B-galactosidase-HindIII fragment A fusion protein. This indicates that existing denaturation-resistant epi-2693 SV40 LARGE T-p-GALACTOSIDASE FUSION PROTEINS 709 topes on large T antigen are retained even when they are present on a fragment within a much larger fusion protein.
The P-galactosidase-HindIII fragment D fusion protein showed no binding to any of the monoclonal antibodies tested or to sera raised against native large T antigen, although binding to sera raised against the Ad2+ D2 protein was observed in Western blotting experiments. This suggests that no antibodies are elicited against denaturation-resistant epitopes in this region during the course of-the response to SV40-transformed cells. Sera and monoclonal antibodies raised against the HindlIl fragment D fusion protein also reacted with denaturation-resistant epitopes present in this region of native large T antigen. Therefore, it appears that presentation of this discrete region of large T antigen, either as the Ad2+ D2 protein or as the HindlIl fragment D fusion protein, induces a different repertoire of antibodies than the repertoire induced by the complete large T antigen molecule when it is presented on transformed cells.
Therefore, it is clear that fusion proteins can play a very important role in the mapping of monoclonal antibody binding sites. This is particularly important because of the problem associated with the use of truncated proteins, where the absence of binding is often taken to correlate with the lack of a binding site, the site being assigned to a larger truncated protein capable of binding the antibody. The procedure can also be used in the production of monoclonal antibodies to unknown open reading frames expressed as part of a P-galactosidase fusion protein, allowing investigation into the function of unknown gene products.
